View ValuationEssity 将来の成長Future 基準チェック /16Essity利益と収益がそれぞれ年間5.1%と2.7%増加すると予測されています。EPS は年間 増加すると予想されています。自己資本利益率は 3 年後に14.3% 5.6%なると予測されています。主要情報5.1%収益成長率5.64%EPS成長率Household Products 収益成長0%収益成長率2.7%将来の株主資本利益率14.26%アナリストカバレッジGood最終更新日18 May 2026今後の成長に関する最新情報更新なしすべての更新を表示Recent updatesお知らせ • Mar 27Essity AB (Publ) Approves Dividend for the Financial Year 2025Essity AB (publ) at its Annual General Meeting held on March 26, 2026 declared a dividend for the financial year 2025 of SEK 8.75 per share. Record date for the dividend is set to March 30, 2026.お知らせ • Mar 03Essity Announces Executive ChangesEssity has appointed Niklas Westin Sundberg as Chief Digital & Information Officer. He will succeed Carl-Magnus Månsson, who is leaving Essity to take up a new external role. Niklas will become a member of the Executive Management Team and be responsible for the company's continued digital transformation and the Digital Transformation and Business Enablement function. With more than 20 years of experience in digital development in international and complex organizations, Niklas Westin Sundberg has led business-driven IT strategies, cybersecurity work and AI initiatives at global companies such as Kuehne+Nagel and ASSA ABLOY. Niklas Westin Sundberg will take office on April 15, 2026 and will report directly to Ulrika Kolsrud, President and CEO of Essity.お知らせ • Feb 03Essity AB (publ) (OM:ESSITY B) completed the acquisition of Feminine care business from Edgewell Personal Care Company (NYSE:EPC).Essity AB (publ) (OM:ESSITY B) entered into a definitive agreement to acquire Feminine care business from Edgewell Personal Care Company (NYSE:EPC) for $340 million on November 12, 2025. The feminine care business includes Playtex®, Stayfree®, Carefree® and o.b.® and Edgewell Personal Care Company will classify the Feminine Care business as discontinued operations in the beginning of first quarter of 2026. Pursuant to the terms of the Purchase Agreement, the Edgewell Personal Care Company is entitled to receive a termination fee of $15 million from Essity AB. if the Purchase Agreement is terminated under certain circumstances. The transaction is expected to close in the first quarter of calendar 2026, subject to customary closing conditions, including the receipt of required regulatory approvals. Edgewell Personal Care Company intends to use the net proceeds from the sale, after taxes and transaction costs, primarily to strengthen its balance sheet while continuing to invest in the long-term growth of its core businesses. Latham & Watkins LLP acted as legal advisor and Perella Weinberg Partners LP acted as financial advisor for Edgewell Personal Care Company. Morgan Stanley AB acted as financial advisor to Essity AB (publ). Essity AB (publ) (OM:ESSITY B) completed the acquisition of Feminine care business from Edgewell Personal Care Company (NYSE:EPC) on February 2, 2026.お知らせ • Jan 22+ 4 more updatesEssity AB (publ) to Report Q1, 2026 Results on Apr 23, 2026Essity AB (publ) announced that they will report Q1, 2026 results on Apr 23, 2026お知らせ • Jan 08Funds Discontinue Legal Action Against Essity over Bond Loans in English CourtsThe funds that have brought an action against Essity in the English courts regarding bond loans issued by the company have chosen to discontinue their action. The case is therefore closed. On October 17, 2024, Essity announced that the company had received a request for early redemption from certain investors regarding bonds maturing in 2029, 2030 and 2031, respectively. In December 2024, the funds initiated proceedings against Essity in the English courts. The parties have entered into an agreement with conditions, among other things, that they have no claims against each other due to Essity's sale of its shares in Vinda. The funds subsequently discontinued their action before the court. Essity has not changed its view that the action was unfounded and has not paid the funds or otherwise compensated them in the dispute.お知らせ • Nov 13Essity AB (publ) (OM:ESSITY B) entered into a definitive agreement to acquire Feminine care business from Edgewell Personal Care Company (NYSE:EPC) for $340 million.Essity AB (publ) (OM:ESSITY B) entered into a definitive agreement to acquire Feminine care business from Edgewell Personal Care Company (NYSE:EPC) for $340 million on November 12, 2025. The feminine care business includes Playtex®, Stayfree®, Carefree® and o.b.® and Edgewell Personal Care Company will classify the Feminine Care business as discontinued operations in the beginning of first quarter of 2026 and intends to use the net proceeds from the sale, after taxes and transaction costs, primarily to strengthen its balance sheet while continuing to invest in the long-term growth of its core businesses. Pursuant to the terms of the Purchase Agreement, the Company is entitled to receive a termination fee of $15 million from Essity AB. if the Purchase Agreement is terminated under certain circumstances The transaction is expected to close in the first quarter of calendar 2026, subject to customary closing conditions, including the receipt of required regulatory approvals. Latham & Watkins LLP acted as legal advisor and Perella Weinberg Partners LP acted as financial advisor for Edgewell Personal Care Company. Morgan Stanley AB acted as financial advisor to Essity AB (publ).お知らせ • Oct 24+ 1 more updateEssity AB (publ) Announces Executive Changes, Effective January 1, 2026Essity AB (Publ) announced executive changes. Tuomas Yrjölä, President Global Marketing & Innovation, has been appointed President Personal Care. Volker Zöller, President Consumer Goods EMEA, has been appointed President Consumer Tissue. Anand Chandarana and Pablo Fuentes have been appointed President Health & Medical and President Professional Hygiene, respectively, also in the new organization. The changes will apply as of January 1, 2026.お知らせ • Sep 20Donato Giorgio Leaves as President Global Supply Chain and Member of the Executive Management Team of Essity, Effective October 31, 2025Essity announced that Donato Giorgio, President Global Supply Chain and member of the Executive Management Team, will leave the company. Donato Giorgio joined Essity in 2009 and has held various leadership positions within Essity's global manufacturing and supply chain. In 2015, he became a member of the Executive Management Team and under his leadership, the company has developed its sustainable manufacturing and circular resource solutions. Donato Giorgio will leave his position on October 31, 2025. The recruitment process for his successor has been initiated.お知らせ • Aug 16Essity Appoints Anand Chandarana as President of Business Unit Health & Medical, Effective from September 1, 2025Essity announced appointment ofAnand Chandarana as President of Business Unit Health & Medical. He will assume the role on September 1, 2025, and will also join the company’s Executive Management Team. Anand Chandarana has been with Essity and the business unit Health & Medical since 2020, most recently as Vice President Commercial Development. He has previously worked 17 years and held several senior positions at the medical solutions company Mölnlycke Health Care. Anand Chandarana will report to Ulrika Kolsrud, President and CEO of Essity. He is a citizen of both the UK and Sweden and will be based in Gothenburg. Business Unit Health & Medical offers products and solutions under the categories Incontinence Products Health Care, Wound Care, Compression therapy and Orthopedics under leading brands such as TENA, Leukoplast, Cutimed, Hydrofera BLUE, JOBST, Delta-Cast, and Actimove.Board Change • Aug 14High number of new directorsThere are 6 new directors who have joined the board in the last 3 years. Director Katarina Martinson was the last director to join the board, commencing their role in 2025. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model.Board Change • Jun 23High number of new directorsThere are 6 new directors who have joined the board in the last 3 years. Director Katarina Martinson was the last director to join the board, commencing their role in 2025. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model.お知らせ • May 09+ 1 more updateEssity AB (Publ) Appoints Ulrika Kolsrud as CEO, Effective June 1, 2025Essity AB's Board of Directors has appointed Ulrika Kolsrud as CEO, effective June 1, 2025. Ulrika Kolsrud, currently President of Essity’s business unit Health & Medical, succeeds Magnus Groth, who earlier this year informed the Board that he will leave his position during the year. Ulrika has extensive and broad experience across the industries in which Essity operates, having worked in all areas of the value chain, such as innovation, production, and sales. She has been a member of the Executive Management Team since 2015, and since 2019 she has been successfully heading Health & Medical. Ulrika Kolsrud is 54 years old and holds a Master of Science in Engineering from Chalmers University of Technology.お知らせ • Apr 29Essity AB (publ) (OM:ESSITY B) commences an Equity Buyback Plan for 60,946,249 shares, representing 8.79% of its issued share capital, under the authorization approved on March 27, 2025.Essity AB (publ) (OM:ESSITY B) commences share repurchases on April 24, 2025, under the program mandated by the shareholders in the Annual General Meeting held on March 27, 2025. As per the mandate, the company is authorized to repurchase up to 60,946,249 B shares, representing 8.79% of its issued share capital. The shares shall be repurchased such that the company does not hold more than 10% of its issued share capital. The shares will be repurchased at a price on Nasdaq Stockholm at a price within the at each time prevailing price interval for the share on the marketplace, meaning the interval between the highest purchase price and the lowest selling price. The purpose of the proposed authorization is to be able to adapt the company’s capital structure. The repurchased shares will be used as payment or financing on account of acquisitions of companies or businesses, and thereby contribute to increased shareholder value. The program will be valid until the Annual General Meeting in 2026. As of February 20, 2025, the company had 702,342,489 issued shares consisting of 58,973,654 are class A shares and 643,368,835 are class B shares including 9,288,000 B shares in treasury. On April 23, 2025, the company announced a share repurchase program. Under the program, the company will repurchase up to SEK 3,000 million worth of its B shares. The repurchased shares are expected to be cancelled. The share repurchase will be financed using cash flow from current operations after the ordinary dividend with the ambition to continue with share buybacks over time as a recurring part of the company’s capital allocation. The repurchases will commence from April 24, 2025, and will be valid till Annual General Meeting of 2026.お知らせ • Apr 24+ 2 more updatesEssity AB (publ) to Report Q4, 2025 Results on Jan 22, 2026Essity AB (publ) announced that they will report Q4, 2025 results on Jan 22, 2026お知らせ • Mar 27+ 1 more updateEssity AB (Publ) Announces Board Changes, Effective March 27, 2025Essity AB (publ) at its Annual General Meeting held on March 27, 2025, Alexander Lacik and Katarina Martinson were elected as a new directors. Ewa Björling had declined re-election. Jan Gurander was elected Chairman of the Board.お知らせ • Mar 24Essity AB (publ) to Report Q1, 2025 Results on Apr 24, 2025Essity AB (publ) announced that they will report Q1, 2025 results at 7:00 AM, Central European Standard Time on Apr 24, 2025お知らせ • Feb 22Essity AB (publ), Annual General Meeting, Mar 27, 2025Essity AB (publ), Annual General Meeting, Mar 27, 2025, at 14:00 W. Europe Standard Time. Location: at stockholm waterfront congress centre, nils ericsons plan 4, stockholm Sweden業績と収益の成長予測BIT:1ESSI - アナリストの将来予測と過去の財務データ ( )SEK Millions日付収益収益フリー・キャッシュフロー営業活動によるキャッシュ平均アナリスト数12/31/2028147,39814,19512,99821,4771112/31/2027143,83513,22811,90619,9981412/31/2026139,10912,08410,26919,603143/31/2026136,69512,4749,57116,782N/A12/31/2025138,49412,6568,35615,459N/A9/30/2025141,60412,2266,35213,648N/A6/30/2025143,24012,2957,91315,036N/A3/31/2025145,67212,4798,87716,052N/A12/31/2024145,54611,8739,36616,801N/A9/30/2024144,36611,88814,17221,251N/A6/30/2024145,1849,97616,08023,412N/A3/31/2024145,6459,12715,66422,738N/A12/31/2023147,1479,27514,67821,568N/A9/30/2023129,5037,79211,78316,952N/A6/30/2023132,5207,8617,12012,241N/A3/31/2023133,3716,9737,63212,876N/A12/31/2022131,3204,6687,44412,874N/A9/30/2022146,5655,3407,01213,992N/A6/30/2022137,6016,5098,01515,205N/A3/31/2022128,6406,7947,79415,250N/A12/31/2021101,4666,8239,44614,667N/A9/30/2021118,5979,2787,49515,291N/A6/30/2021116,1298,8076,65914,140N/A3/31/2021115,5689,1258,83215,757N/A12/31/2020121,75210,22811,21217,819N/A9/30/2020124,48210,30412,27218,312N/A6/30/2020128,37010,51614,30319,826N/A3/31/2020132,03110,70213,91119,425N/A12/31/2019128,9759,216N/A19,351N/A9/30/2019126,4019,903N/A18,172N/A6/30/2019123,4838,414N/A16,442N/A3/31/2019121,1368,175N/A14,654N/A12/31/2018118,5007,886N/A13,160N/A9/30/2018116,0527,372N/A12,471N/A6/30/2018113,5838,474N/A12,432N/A3/31/2018112,0178,116N/A12,246N/A12/31/2017109,2658,116N/A12,729N/A9/30/2017107,3736,212N/A12,884N/A6/30/2017105,4305,853N/A13,113N/A3/31/2017102,2583,748N/A13,968N/A12/31/2016101,2383,800N/A12,778N/A12/31/201598,5196,129N/A10,780N/Aもっと見るアナリストによる今後の成長予測収入対貯蓄率: 1ESSIの予測収益成長率 (年間5.1% ) は 貯蓄率 ( 3.3% ) を上回っています。収益対市場: 1ESSIの収益 ( 5.1% ) Italian市場 ( 11% ) よりも低い成長が予測されています。高成長収益: 1ESSIの収益は増加すると予測されていますが、大幅には増加しません。収益対市場: 1ESSIの収益 ( 2.7% ) Italian市場 ( 5.7% ) よりも低い成長が予測されています。高い収益成長: 1ESSIの収益 ( 2.7% ) 20%よりも低い成長が予測されています。一株当たり利益成長率予想将来の株主資本利益率将来のROE: 1ESSIの 自己資本利益率 は、3年後には低くなると予測されています ( 14.3 %)。成長企業の発掘7D1Y7D1Y7D1YHousehold 業界の高成長企業。View Past Performance企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/05/20 09:09終値2026/05/20 00:00収益2026/03/31年間収益2025/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Essity AB (publ) 14 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。24 アナリスト機関null nullABG Sundal CollierPatrick FolanBarclaysIain SimpsonBarclays21 その他のアナリストを表示
お知らせ • Mar 27Essity AB (Publ) Approves Dividend for the Financial Year 2025Essity AB (publ) at its Annual General Meeting held on March 26, 2026 declared a dividend for the financial year 2025 of SEK 8.75 per share. Record date for the dividend is set to March 30, 2026.
お知らせ • Mar 03Essity Announces Executive ChangesEssity has appointed Niklas Westin Sundberg as Chief Digital & Information Officer. He will succeed Carl-Magnus Månsson, who is leaving Essity to take up a new external role. Niklas will become a member of the Executive Management Team and be responsible for the company's continued digital transformation and the Digital Transformation and Business Enablement function. With more than 20 years of experience in digital development in international and complex organizations, Niklas Westin Sundberg has led business-driven IT strategies, cybersecurity work and AI initiatives at global companies such as Kuehne+Nagel and ASSA ABLOY. Niklas Westin Sundberg will take office on April 15, 2026 and will report directly to Ulrika Kolsrud, President and CEO of Essity.
お知らせ • Feb 03Essity AB (publ) (OM:ESSITY B) completed the acquisition of Feminine care business from Edgewell Personal Care Company (NYSE:EPC).Essity AB (publ) (OM:ESSITY B) entered into a definitive agreement to acquire Feminine care business from Edgewell Personal Care Company (NYSE:EPC) for $340 million on November 12, 2025. The feminine care business includes Playtex®, Stayfree®, Carefree® and o.b.® and Edgewell Personal Care Company will classify the Feminine Care business as discontinued operations in the beginning of first quarter of 2026. Pursuant to the terms of the Purchase Agreement, the Edgewell Personal Care Company is entitled to receive a termination fee of $15 million from Essity AB. if the Purchase Agreement is terminated under certain circumstances. The transaction is expected to close in the first quarter of calendar 2026, subject to customary closing conditions, including the receipt of required regulatory approvals. Edgewell Personal Care Company intends to use the net proceeds from the sale, after taxes and transaction costs, primarily to strengthen its balance sheet while continuing to invest in the long-term growth of its core businesses. Latham & Watkins LLP acted as legal advisor and Perella Weinberg Partners LP acted as financial advisor for Edgewell Personal Care Company. Morgan Stanley AB acted as financial advisor to Essity AB (publ). Essity AB (publ) (OM:ESSITY B) completed the acquisition of Feminine care business from Edgewell Personal Care Company (NYSE:EPC) on February 2, 2026.
お知らせ • Jan 22+ 4 more updatesEssity AB (publ) to Report Q1, 2026 Results on Apr 23, 2026Essity AB (publ) announced that they will report Q1, 2026 results on Apr 23, 2026
お知らせ • Jan 08Funds Discontinue Legal Action Against Essity over Bond Loans in English CourtsThe funds that have brought an action against Essity in the English courts regarding bond loans issued by the company have chosen to discontinue their action. The case is therefore closed. On October 17, 2024, Essity announced that the company had received a request for early redemption from certain investors regarding bonds maturing in 2029, 2030 and 2031, respectively. In December 2024, the funds initiated proceedings against Essity in the English courts. The parties have entered into an agreement with conditions, among other things, that they have no claims against each other due to Essity's sale of its shares in Vinda. The funds subsequently discontinued their action before the court. Essity has not changed its view that the action was unfounded and has not paid the funds or otherwise compensated them in the dispute.
お知らせ • Nov 13Essity AB (publ) (OM:ESSITY B) entered into a definitive agreement to acquire Feminine care business from Edgewell Personal Care Company (NYSE:EPC) for $340 million.Essity AB (publ) (OM:ESSITY B) entered into a definitive agreement to acquire Feminine care business from Edgewell Personal Care Company (NYSE:EPC) for $340 million on November 12, 2025. The feminine care business includes Playtex®, Stayfree®, Carefree® and o.b.® and Edgewell Personal Care Company will classify the Feminine Care business as discontinued operations in the beginning of first quarter of 2026 and intends to use the net proceeds from the sale, after taxes and transaction costs, primarily to strengthen its balance sheet while continuing to invest in the long-term growth of its core businesses. Pursuant to the terms of the Purchase Agreement, the Company is entitled to receive a termination fee of $15 million from Essity AB. if the Purchase Agreement is terminated under certain circumstances The transaction is expected to close in the first quarter of calendar 2026, subject to customary closing conditions, including the receipt of required regulatory approvals. Latham & Watkins LLP acted as legal advisor and Perella Weinberg Partners LP acted as financial advisor for Edgewell Personal Care Company. Morgan Stanley AB acted as financial advisor to Essity AB (publ).
お知らせ • Oct 24+ 1 more updateEssity AB (publ) Announces Executive Changes, Effective January 1, 2026Essity AB (Publ) announced executive changes. Tuomas Yrjölä, President Global Marketing & Innovation, has been appointed President Personal Care. Volker Zöller, President Consumer Goods EMEA, has been appointed President Consumer Tissue. Anand Chandarana and Pablo Fuentes have been appointed President Health & Medical and President Professional Hygiene, respectively, also in the new organization. The changes will apply as of January 1, 2026.
お知らせ • Sep 20Donato Giorgio Leaves as President Global Supply Chain and Member of the Executive Management Team of Essity, Effective October 31, 2025Essity announced that Donato Giorgio, President Global Supply Chain and member of the Executive Management Team, will leave the company. Donato Giorgio joined Essity in 2009 and has held various leadership positions within Essity's global manufacturing and supply chain. In 2015, he became a member of the Executive Management Team and under his leadership, the company has developed its sustainable manufacturing and circular resource solutions. Donato Giorgio will leave his position on October 31, 2025. The recruitment process for his successor has been initiated.
お知らせ • Aug 16Essity Appoints Anand Chandarana as President of Business Unit Health & Medical, Effective from September 1, 2025Essity announced appointment ofAnand Chandarana as President of Business Unit Health & Medical. He will assume the role on September 1, 2025, and will also join the company’s Executive Management Team. Anand Chandarana has been with Essity and the business unit Health & Medical since 2020, most recently as Vice President Commercial Development. He has previously worked 17 years and held several senior positions at the medical solutions company Mölnlycke Health Care. Anand Chandarana will report to Ulrika Kolsrud, President and CEO of Essity. He is a citizen of both the UK and Sweden and will be based in Gothenburg. Business Unit Health & Medical offers products and solutions under the categories Incontinence Products Health Care, Wound Care, Compression therapy and Orthopedics under leading brands such as TENA, Leukoplast, Cutimed, Hydrofera BLUE, JOBST, Delta-Cast, and Actimove.
Board Change • Aug 14High number of new directorsThere are 6 new directors who have joined the board in the last 3 years. Director Katarina Martinson was the last director to join the board, commencing their role in 2025. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model.
Board Change • Jun 23High number of new directorsThere are 6 new directors who have joined the board in the last 3 years. Director Katarina Martinson was the last director to join the board, commencing their role in 2025. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model.
お知らせ • May 09+ 1 more updateEssity AB (Publ) Appoints Ulrika Kolsrud as CEO, Effective June 1, 2025Essity AB's Board of Directors has appointed Ulrika Kolsrud as CEO, effective June 1, 2025. Ulrika Kolsrud, currently President of Essity’s business unit Health & Medical, succeeds Magnus Groth, who earlier this year informed the Board that he will leave his position during the year. Ulrika has extensive and broad experience across the industries in which Essity operates, having worked in all areas of the value chain, such as innovation, production, and sales. She has been a member of the Executive Management Team since 2015, and since 2019 she has been successfully heading Health & Medical. Ulrika Kolsrud is 54 years old and holds a Master of Science in Engineering from Chalmers University of Technology.
お知らせ • Apr 29Essity AB (publ) (OM:ESSITY B) commences an Equity Buyback Plan for 60,946,249 shares, representing 8.79% of its issued share capital, under the authorization approved on March 27, 2025.Essity AB (publ) (OM:ESSITY B) commences share repurchases on April 24, 2025, under the program mandated by the shareholders in the Annual General Meeting held on March 27, 2025. As per the mandate, the company is authorized to repurchase up to 60,946,249 B shares, representing 8.79% of its issued share capital. The shares shall be repurchased such that the company does not hold more than 10% of its issued share capital. The shares will be repurchased at a price on Nasdaq Stockholm at a price within the at each time prevailing price interval for the share on the marketplace, meaning the interval between the highest purchase price and the lowest selling price. The purpose of the proposed authorization is to be able to adapt the company’s capital structure. The repurchased shares will be used as payment or financing on account of acquisitions of companies or businesses, and thereby contribute to increased shareholder value. The program will be valid until the Annual General Meeting in 2026. As of February 20, 2025, the company had 702,342,489 issued shares consisting of 58,973,654 are class A shares and 643,368,835 are class B shares including 9,288,000 B shares in treasury. On April 23, 2025, the company announced a share repurchase program. Under the program, the company will repurchase up to SEK 3,000 million worth of its B shares. The repurchased shares are expected to be cancelled. The share repurchase will be financed using cash flow from current operations after the ordinary dividend with the ambition to continue with share buybacks over time as a recurring part of the company’s capital allocation. The repurchases will commence from April 24, 2025, and will be valid till Annual General Meeting of 2026.
お知らせ • Apr 24+ 2 more updatesEssity AB (publ) to Report Q4, 2025 Results on Jan 22, 2026Essity AB (publ) announced that they will report Q4, 2025 results on Jan 22, 2026
お知らせ • Mar 27+ 1 more updateEssity AB (Publ) Announces Board Changes, Effective March 27, 2025Essity AB (publ) at its Annual General Meeting held on March 27, 2025, Alexander Lacik and Katarina Martinson were elected as a new directors. Ewa Björling had declined re-election. Jan Gurander was elected Chairman of the Board.
お知らせ • Mar 24Essity AB (publ) to Report Q1, 2025 Results on Apr 24, 2025Essity AB (publ) announced that they will report Q1, 2025 results at 7:00 AM, Central European Standard Time on Apr 24, 2025
お知らせ • Feb 22Essity AB (publ), Annual General Meeting, Mar 27, 2025Essity AB (publ), Annual General Meeting, Mar 27, 2025, at 14:00 W. Europe Standard Time. Location: at stockholm waterfront congress centre, nils ericsons plan 4, stockholm Sweden